《全日总结》恒指涨58点 汇控友邦支撑 石药升逾8%
美国财长努钦称两周内与中国国务院副总理刘鹤进行贸易谈判，市场传出中国再度购买美国大豆，港股今日个别发展。恒指高开77点後，最多升169点见26,391点，最终收市升58点或0.2%，报26,281点；国指跌16点或0.2%，收报10,271点。大市全日成交总额752.24亿元。沪、深港通南下交易录得净流入金额分别为2.88亿至4.09亿元人民币。
蓝筹股方面，汇控(00005.HK)升0.8%收59.95元，友邦(01299.HK)升1.5%收76.05元，两者带动恒指上升60点。腾讯(00700.HK)跌不足0.1%收335.6元，中移动(00941.HK)升0.9%收65.2元。内银股建行(00939.HK)、工行(01398.HK)及中行(03988.HK)各跌0.3%至0.6%，内险股中国平安(02318.HK)及国寿(02628.HK)各跌0.3%及0.4%。
此外，港交所(00388.HK)平收报225.8元，舜宇光学(02382.HK)升1.9%，港铁(00066.HK)跌0.8%，中电(00002.HK)升1.2%，金沙中国(01928.HK)跌1.5%，为跌幅最大蓝筹。
中国太保(02601.HK)拟发行GDR遭大行唱淡，股价跌4.3%，为跌幅最大国指成分股。其他国指成分股方面，中电信(00728.HK)跌0.8%，农行(01288.HK)跌1%，复星国际(00656.HK)跌2.7%。
据报内地第二轮带量采购部分药品降价逾50%，医药股个别发展，国药(01099.HK)及绿叶制药(02186.HK)各跌2.4%及1%，中生制药(01177.HK)反覆升1.2%。石药(01093.HK)附属研发抗体获美国食品药品监督管理局颁发骨癌治疗孤儿药资格认定，股价急升8.5%，为升幅最大蓝筹及国指成分股。
基建铁路股回吐，中车时代电气(03898.HK)及中铁建(01186.HK)各跌3.5%及3%，中交建(01800.HK)跌2.2%。内房股普遍走弱，富力(02777.HK)跌2.3%，融创中国(01918.HK)及世茂(00813.HK)均跌1.7%。
科网股个别发展，IGG(00799.HK)及美团点评(03690.HK)股价均升近2.9%，中软(00354.HK)、易鑫(02858.HK)及金山软件(03888.HK)各跌3.4%、1.5%及1.7%。油价上升，航空股走软，国泰(00293.HK)股价失守10元关，收跌1.4%。国航(00753.HK)亦跌1.3%。
腾邦(06880.HK)现炒作，股价飙升1.92倍。龙辉国际(01007.HK)股价午後急泻，全日急跌61.8%，成交急增至近2亿元，公司主席早前转换11.83亿股可换股股份。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app！
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
